Researchers are very enthusiastic about Olaparib, a new cancer drug, that has performed well in preliminary drug trials. Nineteen patients were administered the drug, and showed considerable shrinking -- or stabilization -- of tumors. The cases included those with inherited forms of advanced breast, ovarian and prostate cancers.

To read a bbc.co.uk article on this story, please visit the link below.